28 Jul
GASTRO-HEP
Taribavirin Versus Ribavirin in Treatment-Naive Hepatitis C Patients As reported in the October issue of Hepatology, a phase IIb, randomized, open-label, active-controlled, parallel- group study was conducted to evaluate the efficacy of weight-based dosing of taribavirin, an oral prodrug of ribavirin. The patient population consisted of 278 treatment-naive patients with genotype 1 chronic hepatitis C [...]